These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 28232750)
1. Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes. Ryckbosch SM; Wender PA; Pande VS Nat Commun; 2017 Feb; 8(1):6. PubMed ID: 28232750 [TBL] [Abstract][Full Text] [Related]
2. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study. Thangsunan P; Tateing S; Hannongbua S; Suree N J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580 [TBL] [Abstract][Full Text] [Related]
3. Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review. Raghuvanshi R; Bharate SB Curr Top Med Chem; 2020; 20(12):1124-1135. PubMed ID: 32209043 [TBL] [Abstract][Full Text] [Related]
4. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain. Rahman GM; Das J J Biomol Struct Dyn; 2015; 33(1):219-32. PubMed ID: 24666138 [TBL] [Abstract][Full Text] [Related]
5. The chemistry and biology of the bryostatins: potential PKC inhibitors in clinical development. Ruan BF; Zhu HL Curr Med Chem; 2012; 19(16):2652-64. PubMed ID: 22506770 [TBL] [Abstract][Full Text] [Related]
6. Deletion of the C26 Methyl Substituent from the Bryostatin Analogue Merle 23 Has Negligible Impact on Its Biological Profile and Potency. Zhao X; Kedei N; Michalowski A; Lewin NE; Keck GE; Blumberg PM Chembiochem; 2018 May; 19(10):1049-1059. PubMed ID: 29517836 [TBL] [Abstract][Full Text] [Related]
7. Toward a biorelevant structure of protein kinase C bound modulators: design, synthesis, and evaluation of labeled bryostatin analogues for analysis with rotational echo double resonance NMR spectroscopy. Loy BA; Lesser AB; Staveness D; Billingsley KL; Cegelski L; Wender PA J Am Chem Soc; 2015 Mar; 137(10):3678-85. PubMed ID: 25710634 [TBL] [Abstract][Full Text] [Related]
8. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action. Kedei N; Telek A; Michalowski AM; Kraft MB; Li W; Poudel YB; Rudra A; Petersen ME; Keck GE; Blumberg PM Biochem Pharmacol; 2013 Feb; 85(3):313-24. PubMed ID: 23146662 [TBL] [Abstract][Full Text] [Related]
9. Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. DeChristopher BA; Loy BA; Marsden MD; Schrier AJ; Zack JA; Wender PA Nat Chem; 2012 Sep; 4(9):705-10. PubMed ID: 22914190 [TBL] [Abstract][Full Text] [Related]
10. Substitution on the A-ring confers to bryopyran analogues the unique biological activity characteristic of bryostatins and distinct from that of the phorbol esters. Keck GE; Poudel YB; Welch DS; Kraft MB; Truong AP; Stephens JC; Kedei N; Lewin NE; Blumberg PM Org Lett; 2009 Feb; 11(3):593-6. PubMed ID: 19113896 [TBL] [Abstract][Full Text] [Related]
11. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D. Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664 [TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism. Abdelnabi R; Staveness D; Near KE; Wender PA; Delang L; Neyts J; Leyssen P Biochem Pharmacol; 2016 Nov; 120():15-21. PubMed ID: 27664855 [TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulation studies on binding of activator and inhibitor to Munc13-1 C1 in the presence of membrane. You Y; Das J J Biomol Struct Dyn; 2022; 40(24):14160-14175. PubMed ID: 34779746 [TBL] [Abstract][Full Text] [Related]
14. Phorbol esters as probes for the study of protein kinase C function. Kazanietz MG; Lorenzo PS Methods Mol Biol; 2003; 233():423-39. PubMed ID: 12840526 [No Abstract] [Full Text] [Related]
15. Insertion Depth Modulates Protein Kinase C-δ-C1b Domain Interactions with Membrane Cholesterol as Revealed by MD Simulations. Judge PT; Overall SA; Barnes AB Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902029 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase C. Modeling of the binding site and prediction of binding constants. Wang S; Milne GW; Nicklaus MC; Marquez VE; Lee J; Blumberg PM J Med Chem; 1994 Apr; 37(9):1326-38. PubMed ID: 8176711 [TBL] [Abstract][Full Text] [Related]
17. Conformationally constrained analogues of diacylglycerol. 12. Ultrapotent protein kinase C ligands based on a chiral 4,4-disubstituted heptono-1,4-lactone template. Lee J; Sharma R; Wang S; Milne GW; Lewin NE; Szallasi Z; Blumberg PM; George C; Marquez VE J Med Chem; 1996 Jan; 39(1):36-45. PubMed ID: 8568825 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin. Irie K; Yanagita RC Chem Rec; 2014 Apr; 14(2):251-67. PubMed ID: 24677503 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase C in cell signaling: strategies for the development of selective inhibitors. Blumberg PM; Acs G; Acs P; Areces LB; Kazanietz MG; Lewin NE; Szallasi Z Agents Actions Suppl; 1995; 47():87-100. PubMed ID: 7785505 [TBL] [Abstract][Full Text] [Related]
20. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family. Chen J; Deng F; Li J; Wang QJ Biochem J; 2008 Apr; 411(2):333-42. PubMed ID: 18076381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]